Literature DB >> 22492868

Relationship between adipose tissue lipolytic activity and skeletal muscle insulin resistance in nondiabetic women.

Faidon Magkos1, Elisa Fabbrini, Caterina Conte, Bruce W Patterson, Samuel Klein.   

Abstract

CONTEXT: Increased adipose tissue lipolytic activity is considered an important factor in the pathogenesis of skeletal muscle insulin resistance associated with obesity.
OBJECTIVE: The objective of the study was to evaluate the relationship between the rate of release of free fatty acids (FFA) into plasma and skeletal muscle insulin sensitivity in human subjects.
METHODS: We determined the palmitate rate of appearance (Ra) per kilogram fat-free mass (an index of FFA availability to lean tissues) during basal conditions and during insulin infusion (to simulate postprandial insulin concentrations) and skeletal muscle insulin sensitivity, defined as the percent increase in the glucose rate of disappearance, in 110 nondiabetic women (body mass index 20.6-46.4 kg/m(2)) by using the hyperinsulinemic-euglycemic clamp procedure in conjunction with stable isotope tracer methods.
RESULTS: Basal (r(s) = -0.379, P < 0.001) and insulin-suppressed (r(s) = -0.631, P < 0.001) palmitate Ra correlated negatively with skeletal muscle insulin sensitivity. However, the strength of the correlation was greater for palmitate Ra during insulin infusion than palmitate Ra during basal conditions (P = 0.0007) when lipolytic rates and FFA availability were reduced to less than 20% of basal values. The relative suppression of palmitate Ra correlated directly with the relative stimulation of glucose rate of disappearance during insulin infusion (r(s) = 0.530, P < 0.001).
CONCLUSION: These data suggest that the correlation between FFA kinetics and muscle glucose metabolism is due to multiorgan insulin resistance rather than a direct effect of FFA itself on skeletal muscle insulin action and challenge the view that increased adipose tissue lipolytic rate is an important cause of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492868      PMCID: PMC3387393          DOI: 10.1210/jc.2012-1035

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

Authors:  Elisa Fabbrini; B Selma Mohammed; Faidon Magkos; Kevin M Korenblat; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682

Review 2.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 3.  Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle.

Authors:  Debby P Y Koonen; Jan F C Glatz; Arend Bonen; Joost J F P Luiken
Journal:  Biochim Biophys Acta       Date:  2005-10-01

4.  Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.

Authors:  A T Santomauro; G Boden; M E Silva; D M Rocha; R F Santos; M J Ursich; P G Strassmann; B L Wajchenberg
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

5.  Interaction between glucose and free fatty acid metabolism in human skeletal muscle.

Authors:  D E Kelley; M Mokan; J A Simoneau; L J Mandarino
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Postprandial free fatty acid kinetics are abnormal in upper body obesity.

Authors:  L R Roust; M D Jensen
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

7.  Relationship between body fat mass and free fatty acid kinetics in men and women.

Authors:  Bettina Mittendorfer; Faidon Magkos; Elisa Fabbrini; B Selma Mohammed; Samuel Klein
Journal:  Obesity (Silver Spring)       Date:  2009-07-23       Impact factor: 5.002

8.  Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

Authors:  Kevin M Korenblat; Elisa Fabbrini; B Selma Mohammed; Samuel Klein
Journal:  Gastroenterology       Date:  2008-01-30       Impact factor: 22.682

9.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

Authors:  Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

10.  Adipose tissue fatty acid metabolism in insulin-resistant men.

Authors:  A S T Bickerton; R Roberts; B A Fielding; H Tornqvist; E E Blaak; A J M Wagenmakers; M Gilbert; S M Humphreys; F Karpe; K N Frayn
Journal:  Diabetologia       Date:  2008-05-27       Impact factor: 10.122

View more
  17 in total

1.  Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.

Authors:  Uche Ezeh; Zorayr Arzumanyan; Daria Lizneva; Ruchi Mathur; Yen-Hao Chen; Raymond C Boston; Y-D Ida Chen; Ricardo Azziz
Journal:  Hum Reprod       Date:  2019-02-01       Impact factor: 6.918

2.  Advances in stable isotope tracer methodology part 1: hepatic metabolism via isotopomer analysis and postprandial lipolysis modeling.

Authors:  Cecilia Diniz Behn; Eunsook S Jin; Kate Bubar; Craig Malloy; Elizabeth J Parks; Melanie Cree-Green
Journal:  J Investig Med       Date:  2019-09-24       Impact factor: 2.895

3.  Moderate-Intensity Exercise and High-Intensity Interval Training Affect Insulin Sensitivity Similarly in Obese Adults.

Authors:  Benjamin J Ryan; Michael W Schleh; Cheehoon Ahn; Alison C Ludzki; Jenna B Gillen; Pallavi Varshney; Douglas W Van Pelt; Lisa M Pitchford; Thomas L Chenevert; Rachel A Gioscia-Ryan; Suzette M Howton; Thomas Rode; Scott L Hummel; Charles F Burant; Jonathan P Little; Jeffrey F Horowitz
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

4.  Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort.

Authors:  Luke W Johnston; Stewart B Harris; Ravi Retnakaran; Adria Giacca; Zhen Liu; Richard P Bazinet; Anthony J Hanley
Journal:  Diabetologia       Date:  2017-12-24       Impact factor: 10.122

5.  Altered maternal lipid metabolism is associated with higher inflammation in obese women during late pregnancy.

Authors:  Rachel A Tinius; Alison G Cahill; Eric A Strand; W Todd Cade
Journal:  Integr Obes Diabetes       Date:  2015-12-19

6.  Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity.

Authors:  Nikki C Bush; Rita Basu; Robert A Rizza; K Sreekumaran Nair; Sundeep Khosla; Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2012-08-29       Impact factor: 5.958

7.  In vivo 2H2O administration reveals impaired triglyceride storage in adipose tissue of insulin-resistant humans.

Authors:  Candice A Allister; Li-fen Liu; Cindy A Lamendola; Colleen M Craig; Samuel W Cushman; Marc K Hellerstein; Tracey L McLaughlin
Journal:  J Lipid Res       Date:  2014-11-23       Impact factor: 5.922

8.  Genetic deletion of Wdr13 improves the metabolic phenotype of Lepr (db/db) mice by modulating AP1 and PPARγ target genes.

Authors:  Vijay P Singh; Chandrashekaran Gurunathan; Sachin Singh; Bhavtaran Singh; B Jyothi Lakshmi; Arun P Mishra; Satish Kumar
Journal:  Diabetologia       Date:  2014-11-23       Impact factor: 10.122

9.  Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity.

Authors:  Jordan A Levine; Jung Min Han; Anna Wolska; Sierra R Wilson; Tushar P Patel; Alan T Remaley; Vipul Periwal; Jack A Yanovski; Andrew P Demidowich
Journal:  J Clin Lipidol       Date:  2020-08-04       Impact factor: 4.766

10.  Factors regulating subcutaneous adipose tissue storage, fibrosis, and inflammation may underlie low fatty acid mobilization in insulin-sensitive obese adults.

Authors:  Douglas W Van Pelt; Lisa M Guth; Abigail Y Wang; Jeffrey F Horowitz
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-05       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.